Moderna‘s (NASDAQ:MRNA | MRNA Price Prediction) push into cancer treatment is drawing heavy buying as a closely followed ...

Moderna Inc. MRNA shares are trading higher Monday as investors position ahead of detailed Phase 3 melanoma data for its ...

It was a head-turning headline. Here's why the market was buzzing.

Moderna has surged more than 650% this year on cancer vaccine excitement, but analyst targets sit far below the current share ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

At the European Society of Medical Oncology meeting in Madrid this weekend, analysts will be watching for detailed data on ...

Following last month's super rally, a growing number of analysts are now calling for caution.

His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia ...

Moderna (MRNA) stock has gained 282.6% over the past three months, outpacing a 4.1% return for the S&P 500. The shares ...

Shares of Moderna ( MRNA ), an mRNA medicines developer, sank almost 8% on Friday, pulling back from a substantial run that ...

CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a ...

Moderna stock gains on reports of an initiative to accelerate cancer vaccine development. Here’s why caution is warranted in ...